Additionally, Ezh2 blockage enhances anti-inflammatory Socs3 that inhibits hyperinflammation in sepsis (here and others), multiple sclerosis, and glucose-activated peritoneal fibrosis [60,69,73]. The gene discussed is SOCS3; the disease is Peritoneal Fibrosis.